Queensland Subordinate Legislation as Made

MEDICINES AND POISONS (MEDICINES) AMENDMENT REGULATION (NO. 2) 2023 - REG 4

4 Insertion of new s 6A

After section 6 —
insert—

6A Exemption for S3 naloxone treatment programs—Act, s 7

(1) For section 7(1) of the Act, each of the following activities with the following substances is prescribed—

(a) supplying, by wholesale, stock of S3 naloxone for a naloxone treatment program;

(b) giving 1 or more doses of S3 naloxone obtained under a naloxone treatment program to a person;

(c) administering S3 naloxone obtained under a naloxone treatment program to a person.

(2) However, subsection (3) applies to an activity mentioned in subsection (1)(b) carried out by a person performing a function under a naloxone treatment program.

(3) The activity is prescribed only to the extent—

(a) the person is appropriately qualified; and

(b) the person, when carrying out the activity, gives instructions about—

(i) how to recognise signs and symptoms of suspected opioid overdose; and

(ii) how to administer the S3 naloxone.

(4) In this section—

"naloxone treatment program" means a program set up by an entity of the State or Commonwealth to make S3 naloxone widely available for treating opioid overdose.

"S3 naloxone" means naloxone in a manufacturer’s pack for the treatment of opioid overdose, other than naloxone that is an S4 medicine.